These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9484812

  • 1. Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.
    Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW, Hudes GR.
    Br J Cancer; 1998 Feb; 77(4):562-6. PubMed ID: 9484812
    [Abstract] [Full Text] [Related]

  • 2. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S, McCauley RA, Dexter DW, Hudes GR.
    Br J Cancer; 2001 Sep 01; 85(5):735-40. PubMed ID: 11531260
    [Abstract] [Full Text] [Related]

  • 3. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
    Ranganathan S, Dexter DW, Benetatos CA, Hudes GR.
    Biochim Biophys Acta; 1998 Jan 21; 1395(2):237-45. PubMed ID: 9473684
    [Abstract] [Full Text] [Related]

  • 4. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
    Kamath K, Wilson L, Cabral F, Jordan MA.
    J Biol Chem; 2005 Apr 01; 280(13):12902-7. PubMed ID: 15695826
    [Abstract] [Full Text] [Related]

  • 5. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
    Kanakkanthara A, Northcote PT, Miller JH.
    Mol Cancer Ther; 2012 Feb 01; 11(2):393-404. PubMed ID: 22180309
    [Abstract] [Full Text] [Related]

  • 6. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.
    Verdier-Pinard P, Wang F, Martello L, Burd B, Orr GA, Horwitz SB.
    Biochemistry; 2003 May 13; 42(18):5349-57. PubMed ID: 12731876
    [Abstract] [Full Text] [Related]

  • 7. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.
    Wang W, Zhang H, Wang X, Patterson J, Winter P, Graham K, Ghosh S, Lee JC, Katsetos CD, Mackey JR, Tuszynski JA, Wong GK, Ludueña RF.
    Protoplasma; 2017 May 13; 254(3):1163-1173. PubMed ID: 27943021
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B, Staren ED, Iwamura T, Appert HE, Howard JM.
    J Surg Res; 2001 Aug 13; 99(2):179-86. PubMed ID: 11469885
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Isonishi S, Saitou M, Saitou M, Yasuda M, Tanaka T.
    Oncol Rep; 2007 Jul 13; 18(1):195-201. PubMed ID: 17549368
    [Abstract] [Full Text] [Related]

  • 10. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H, Gotanda T, Oku S, Imazono Y, Kubo H, Hanada T, Suzuki S, Inomata K, Kishiye T, Tahara Y, Nishiyama K, Nakagawa M.
    Jpn J Cancer Res; 2002 Sep 13; 93(9):1037-46. PubMed ID: 12359058
    [Abstract] [Full Text] [Related]

  • 11. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ, Giannakakou P, Gunasekera SP, Longley RE, Day BW, Hamel E.
    Mol Pharmacol; 1997 Oct 13; 52(4):613-22. PubMed ID: 9380024
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH, Wang C, Ojima I, Horwitz SB.
    J Nat Prod; 2018 Mar 23; 81(3):600-606. PubMed ID: 29517223
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells.
    Banerjee A.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):598-601. PubMed ID: 12054644
    [Abstract] [Full Text] [Related]

  • 15. Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.
    Liu Q, Cai P, Guo S, Shi J, Sun H.
    Aging (Albany NY); 2020 Feb 28; 12(4):3713-3729. PubMed ID: 32108588
    [Abstract] [Full Text] [Related]

  • 16. Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines.
    Han EK, Gehrke L, Tahir SK, Credo RB, Cherian SP, Sham H, Rosenberg SH, Ng S.
    Eur J Cancer; 2000 Aug 28; 36(12):1565-71. PubMed ID: 10930805
    [Abstract] [Full Text] [Related]

  • 17. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
    Ranganathan S, Dexter DW, Benetatos CA, Chapman AE, Tew KD, Hudes GR.
    Cancer Res; 1996 Jun 01; 56(11):2584-9. PubMed ID: 8653701
    [Abstract] [Full Text] [Related]

  • 18. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H, Kearney CM, Pinney KG.
    Anticancer Res; 2005 Jun 01; 25(6B):3865-70. PubMed ID: 16309172
    [Abstract] [Full Text] [Related]

  • 19. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
    Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA.
    Biochemistry; 1997 Mar 25; 36(12):3554-62. PubMed ID: 9132006
    [Abstract] [Full Text] [Related]

  • 20. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
    Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L, Sikic BI.
    Cancer Res; 1996 Mar 01; 56(5):1091-7. PubMed ID: 8640766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.